Top Markets
Coin of the day
Proteonomix, Inc. Proteonomix, Inc.

Proteonomix, Inc.

PROT
주식 순위 #42572
Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics... Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company’s products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone marrow and administered through IV solution to repair heart tissue. Its products also comprise NC-138, a proprietary matrix of proteins, which act on the skin to enhance activities that reduce wrinkles. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey.
주가
$0.0001
마지막 동기화: 2026-08-11
시가총액
$791.00
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Proteonomix, Inc. (PROT)

카테고리

Proteonomix, Inc. (PROT)의 배당 수익률 기록
Proteonomix, Inc. (주식 심볼: PROT)의 배당 수익률 (TTM)은 2026 기준으로 0입니다.
지난 5년 평균 배당 수익률: 0.00%
Proteonomix, Inc. (PROT)의 배당 수익률 기록: 2026 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
연도 배당 수익률 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 배당 수익률 (TTM)